The accreditation ensures that cancer patients in the UAE now have access to world-class genomic profiling locally, meeting the highest international standards of quality and accuracy
4baseCare, a leader in precision oncology, has achieved a major milestone with CAP (College of American Pathologists) accreditation for its genomics lab at Dubai Science Park, established in partnership with Innovate Life Sciences Fz-LLC. The accreditation ensures that cancer patients in the UAE now have access to world-class genomic profiling locally, meeting the highest international standards of quality and accuracy.
By securing CAP accreditation, 4baseCare reaffirms its commitment to advancing cancer care through data-driven, personalised treatment decisions. The Dubai-based facility bridges a critical gap in precision oncology, eliminating the need for patients to seek genomic testing solutions outside of the UAE.
“Our mission is to democratize access to high-quality genomic insights, empowering oncologists with cutting-edge molecular data to drive better patient outcomes,” said Dr Sudharshan Elangovan, VP of Global Operations, 4baseCare.
Syed Hussaini, General Manager, Innovate Life Sciences, added, “This achievement underscores our dedication to quality and innovation, strengthening our mission to make precision medicine more accessible and affordable across the Middle East and beyond.”
